Review





Similar Products

anti vsv g antibody  (ATCC)
97
ATCC anti vsv g antibody
Anti Vsv G Antibody, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vsv+g/I1-Hybridoma/bio_rxiv__64898__2026__05__04__722688-110-21-27
Average 97 stars, based on 1 article reviews
anti vsv g antibody - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
anti vsv g antibodies  (ATCC)
97
ATCC anti vsv g antibodies
Anti Vsv G Antibodies, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vsv+g/I1-Hybridoma/pmc13119501-117-15-22
Average 97 stars, based on 1 article reviews
anti vsv g antibodies - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
i1 anti vsv g hybridoma supernatant  (ATCC)
97
ATCC i1 anti vsv g hybridoma supernatant
I1 Anti Vsv G Hybridoma Supernatant, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vsv+g/I1-Hybridoma/us12589104-3786-21-25
Average 97 stars, based on 1 article reviews
i1 anti vsv g hybridoma supernatant - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
anti vsv g monoclonal antibody  (Absolute Biotech Inc)
86
Absolute Biotech Inc anti vsv g monoclonal antibody
Anti Vsv G Monoclonal Antibody, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vsv+g/anti+g+vsv/pm41824449-948-12-16
Average 86 stars, based on 1 article reviews
anti vsv g monoclonal antibody - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
vsv g  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology vsv g
Cellular antiviral host defenses are dependent on LATS1. A and B , plaque assay for viral titers from supernatants of WT and Lats1 −/− MEF cells infected <t>with</t> <t>VSV</t> (MOI 0.1) ( A ) or HSV-1 (MOI 0.4) for 16 h. C , immunoblot analysis ( left panel ) and relative quantification ( right panel ) for VSV encoded glycoprotein, G <t>(VSV-G)</t> in WT and Lats1 −/− MEF cells infected with VSV (MOI 0.1) for the indicated times. D , immunoblot analysis ( left panel ) and relative quantification ( right panel ) of HSV-1 encoded immediate early transcription factor, ICP4 (HSV-1 ICP4) expression in WT and Lats1 −/− MEF cells infected with HSV-1 (MOI 0.1) for the indicated times. E and F , fluorescent imaging of WT and Lats1 −/− MEF cells infected with VSV-GFP (MOI 0.1) ( E ) or HSV-1-GFP (MOI 0.1) ( F ) for 24 h. Left to right : bright field, GFP, merged channels. Scale bar = 170 μm. Statistical significance was determined using student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).
Vsv G, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vsv+g/VSV-G+Antibody/pmc12927312-143-11-16
Average 94 stars, based on 1 article reviews
vsv g - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Cellular antiviral host defenses are dependent on LATS1. A and B , plaque assay for viral titers from supernatants of WT and Lats1 −/− MEF cells infected with VSV (MOI 0.1) ( A ) or HSV-1 (MOI 0.4) for 16 h. C , immunoblot analysis ( left panel ) and relative quantification ( right panel ) for VSV encoded glycoprotein, G (VSV-G) in WT and Lats1 −/− MEF cells infected with VSV (MOI 0.1) for the indicated times. D , immunoblot analysis ( left panel ) and relative quantification ( right panel ) of HSV-1 encoded immediate early transcription factor, ICP4 (HSV-1 ICP4) expression in WT and Lats1 −/− MEF cells infected with HSV-1 (MOI 0.1) for the indicated times. E and F , fluorescent imaging of WT and Lats1 −/− MEF cells infected with VSV-GFP (MOI 0.1) ( E ) or HSV-1-GFP (MOI 0.1) ( F ) for 24 h. Left to right : bright field, GFP, merged channels. Scale bar = 170 μm. Statistical significance was determined using student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).

Journal: The Journal of Biological Chemistry

Article Title: Cytosolic nucleic acid sensing triggers type I interferon activation via the Hippo kinase LATS1

doi: 10.1016/j.jbc.2026.111204

Figure Lengend Snippet: Cellular antiviral host defenses are dependent on LATS1. A and B , plaque assay for viral titers from supernatants of WT and Lats1 −/− MEF cells infected with VSV (MOI 0.1) ( A ) or HSV-1 (MOI 0.4) for 16 h. C , immunoblot analysis ( left panel ) and relative quantification ( right panel ) for VSV encoded glycoprotein, G (VSV-G) in WT and Lats1 −/− MEF cells infected with VSV (MOI 0.1) for the indicated times. D , immunoblot analysis ( left panel ) and relative quantification ( right panel ) of HSV-1 encoded immediate early transcription factor, ICP4 (HSV-1 ICP4) expression in WT and Lats1 −/− MEF cells infected with HSV-1 (MOI 0.1) for the indicated times. E and F , fluorescent imaging of WT and Lats1 −/− MEF cells infected with VSV-GFP (MOI 0.1) ( E ) or HSV-1-GFP (MOI 0.1) ( F ) for 24 h. Left to right : bright field, GFP, merged channels. Scale bar = 170 μm. Statistical significance was determined using student’s t test (∗∗∗ p < 0.001, ∗∗ p < 0.01, and ∗ p < 0.05).

Article Snippet: Primary antibodies used in this study were FLAG (Sigma Life Sciences); VSV-G, HSV-1 ICP4, HSP90, P65 (Santa Cruz Biotechnology); TBK1, p-TBK1, IRF3, p-IRF3, LATS1, p-LATS1, p-YAP, YAP/TAZ, STING, p-STING, p-P65, β-Actin (Cell Signaling Technology); β-Tubulin, GAPDH, HA (Proteintech); P65 (Santa Cruz Biotechnology).

Techniques: Plaque Assay, Infection, Western Blot, Quantitative Proteomics, Expressing, Imaging